Compare QNCX & LODE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QNCX | LODE |
|---|---|---|
| Founded | 2012 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.2M | 167.1M |
| IPO Year | 2019 | N/A |
| Metric | QNCX | LODE |
|---|---|---|
| Price | $3.24 | $4.00 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 2 |
| Target Price | ★ $8.00 | $4.00 |
| AVG Volume (30 Days) | 901.4K | ★ 1.0M |
| Earning Date | 11-12-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,778,445.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1,798.62 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 48.99 |
| 52 Week Low | $0.72 | $1.67 |
| 52 Week High | $4.55 | $10.10 |
| Indicator | QNCX | LODE |
|---|---|---|
| Relative Strength Index (RSI) | 47.72 | 62.36 |
| Support Level | $3.34 | $3.66 |
| Resistance Level | $3.80 | $4.12 |
| Average True Range (ATR) | 0.32 | 0.31 |
| MACD | -0.13 | 0.05 |
| Stochastic Oscillator | 4.38 | 89.06 |
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
Comstock Inc innovates and commercializes technologies that are deployable across entire industries to contribute to energy abundance by efficiently extracting and converting under-utilized natural resources, such as waste and other forms of woody biomass into renewable fuels, and end-of-life electronics into recovered electrification metals. Comstock's innovations group is engaged in developing and using artificial intelligence technologies for advanced materials development.